Choroid plexus and DTI-ALPS track cortical atrophy, possibly glymphatics
Solid methods but mostly showing cross-sectional correlation between ChP enlargement and lower ALPS indices with temporal thinning, not necessarily glymphatic failure.
Ultimately, this paper supports one main point: ChP enlargement and lower DTI-ALPS indices seem to be correlated with lower cortical thickness. The methods and stats are pretty solid, with one benefit being they used amyloid PET to stratify Aβ +/- groups rather than just looking at cognitive measures. However, the results also only showed FDR-corrected significance on mainly temporal cortical thickness effects, and not cognition results. Additionally, “glymphatic” is not necessarily the downstream effect being measured here. Though ChP and DTI-ALPS both are integrated with glymphatic flow, they can be influenced by morphology/atrophy/inflammation and WM microstructure/axonal degeneration/edema, respectively, as well as others. This is more correlation than proven effect. Lastly, these are all cross-sectional results; no measurement of whether or not ChP/ALPS effects precede or follow neurodegeneration.
This is interesting for free water (FW)-based research since effects of FW on CDRSB modulated by APOE ε4 is a direct topic of interest. However, the reinforced atrophy angle kind of reduces that idea… there is no benefit of measuring FW over atrophy unless the signal is significantly stronger, especially since it seems more likely atrophy precedes FW, is less expensive, and is easier to quantify. CDRSB ~ FW x atrophy does not produce significant results, and CDRSB ~ FW x ε4 + atrophy also has shown minimal effect.